Effective Cancer Treatments Follow the Clock
The research team, which included senior author Joseph S. Takahashi, a Howard Hughes Medical Institute investigator at Northwestern University, and senior author Marina P. Antoch at the Cleveland Clinic Lerner Research Institute in Cleveland, Ohio, published its findings February 1, 2005, in the early online edition of the Proceedings of the National Academy of Sciences.
In experiments, which were conducted in mice, the scientists found that the body's internal biological clock affects the survival of immune cells that are targets of the anti-cancer drug cyclophosphamide (CY).
?We became interested in examining this issue because there is a long history of knowledge that chemotherapeutic agents produce different mortality and morbidity at different times of the day,? said Takahashi. The initial experiments with normal mice, performed by Antoch during her tenure in Takahashi's lab, confirmed that animals treated with CY survived better when they received treatment in late afternoon than those whose treatments were initiated early in the morning. Antoch further extended these original findings after she moved to Cleveland and established her research program in the Department of Cancer Biology at the Cleveland Clinic Foundation.
To examine the mechanism for this difference, Antoch and her colleagues used mice that genetically lack different components of the body's internal clock. ?Knowing the molecular mechanism of internal clock function lets us make some important predictions of how these mice may respond to drug treatment,? said Antoch. ?Thus, defects in Clock or Bmal1 genes, which essentially damp the cycles of the internal clock may produce very different effect when compared to defects in Cryptochrome gene, which, in contrast, `jams' the circadian clock at the most active point in its cycle.?
Biological clocks function in the brain as well as lung, liver, heart and skeletal muscles. They operate on a 24-hour, circadian (Latin for "about a day") cycle that governs functions like sleeping and waking, rest and activity, fluid balance, body temperature, cardiac output, oxygen consumption and endocrine gland secretion.
In their experiments, the researchers measured the animals' body weight as an indicator of response to the anti-cancer drug. They discovered that Clock-mutant and Bmal1-knockout mice showed high sensitivity to the drug at any time it was administered - as if the drug were administered early in the morning or late at night. In contrast, the Cryptochrome knockout mice showed more resistance to the drug at all times than did normal mice.
The researchers then tested whether this effect might be due to differences in the metabolic activation of the anti-cancer drug, but found essentially none. ?This was a real surprise, because some of the enzymes involved in activating CY in the liver show circadian rhythms,? said Takahashi. ?We thought that the liver might be activating the drug more strongly at some times, or detoxifying it less effectively, or both.?
However, when the researchers analyzed the activity of the knockout animals' immune system B cells, they found evidence that the activity of the Clock and Bmal1 genes determined the cells' sensitivity to CY.
?Thus, this paper gives us specific mechanistic insight into the role of circadian rhythms in sensitivity to such drugs,? said Takahashi. ?This is not some vague metabolic difference between day and night. This is a tangible difference in the immune system that influences sensitivity.?
The findings may well extend to the effects of other anti-cancer drugs, as well as to radiation therapy and may provide a rationale for adjusting the timing of chemotherapy to make it less toxic. ?There is one more very important clinical application of these findings,? Antoch said, ?as they provide a rationale for developing drugs that can enhance the therapeutic index through the modulation of the circadian clock. We have already started screening sets of chemical compounds for their ability to affect this function. We are also planning additional studies to discover the molecular signals from the circadian machinery to the immune system that might prove to be useful drug targets.?
Jim Keeley - firstname.lastname@example.org
Howard Hughes Medical Institute
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Keeley, Jim. "Effective Cancer Treatments Follow the Clock." Medical News Today. MediLexicon, Intl., 4 Feb. 2005. Web.
24 Oct. 2016. <http://www.medicalnewstoday.com/releases/19597.php>
Keeley, J. (2005, February 4). "Effective Cancer Treatments Follow the Clock." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.